Hester Biosciences Limited

Equities

Market Closed - Bombay S.E. Other stock markets 03:31:01 14/05/2026 pm IST			5-day change	1st Jan Change
1,735.65 ^INR	+1.58%		+4.79%	+9.03%

11/03	Hester Biosciences Gets Board Nod to Divest 43.8% Stake in Subsidiary; Shares Up 3%	MT
11/03	Hester Biosciences approves divestment of 43.81% equity in Texas Lifesciences	RE

Published on 01/30/2025 at 02:00 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Ladies and gentlemen, good day, and welcome to the Hester Biosciences Q3 9 Months FY '25 Earnings Conference Call hosted by ICICI Securities Limited.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

11/03	Hester Biosciences Gets Board Nod to Divest 43.8% Stake in Subsidiary; Shares Up 3%	MT
11/03	Hester Biosciences approves divestment of 43.81% equity in Texas Lifesciences	RE
11/03	Ticop Life Private Limited entered into an agreement to acquire an additional 43.81% stake in Texas Laboratories from Hester Biosciences Limited for INR 92 million.	CI
30/01	Hester Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
30/01	Hester Biosciences Limited, Q3 2026 Earnings Call, Jan 30, 2026
30/01	Hester Biosciences re-appoints Rajiv Gandhi as CEO & MD	RE
24/01	Hester Biosciences Limited Receives the Manufacturing License from the Food & Drugs Control Administration	CI
20/11	Hester Biosciences says Ashish Desai appointed as chief financial officer	RE
20/11	Hester Biosciences Appoints CFO	MT
20/11	Hester Biosciences Limited Appoints Ashish Desai as Key Managerial Personnel, with Effect from 20 November 2025	CI
20/11	Hester Biosciences Limited Appoints Ashish Desai as Chief Financial Officer, with Effect from 20 November 2025	CI
14/11	Hester Biosciences CFO Resigns	MT
12/11	Indian Equities Extend Winning Run on NDA Exit Poll Boost, Global Optimism	MT
12/11	Hester Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
12/11	Hester Biosciences Limited, Q2 2026 Earnings Call, Nov 12, 2025